AAMU
BLUE

Amundi Asset Management US’s bluebird bio BLUE Stock Holding History

Amundi Asset Management US’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-486
Closed -$273K – 1537
2020
Q4 		$273K Hold
486
– – ﹤0.01% 1389
2020
Q3 		$340K Buy
486
+177
+57% +$138K ﹤0.01% 1306
2020
Q2 		$244K Sell
309
-15,642
-98% -$11.8M ﹤0.01% 1356
2020
Q1 		$9.5M Buy
15,951
+4,237
+36% +$4.13M 0.02% 579
2019
Q4 		$13.3M Buy
11,714
+2,408
+26% +$2.62M 0.02% 679
2019
Q3 		$11.1M Buy
9,306
+1,256
+16% +$1.92M 0.02% 677
2019
Q2 		$13.3M Buy
8,050
+875
+12% +$1.51M 0.01% 706
2019
Q1 		$14.6M Sell
7,175
-1,379
-16% -$2.43M 0.02% 616
2018
Q4 		$11K Buy
8,554
+1,135
+15% +$1.74M 0.01% 634
2018
Q3 		$14M Buy
7,419
+1,143
+18% +$2.36M 0.02% 651
2018
Q2 		$12.8M Buy
6,276
+2,570
+69% +$5.86M 0.02% 658
2018
Q1 		$8.2M Buy
+3,706
New +$9.43M 0.01% 734

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Amundi Asset Management US's BLUE Position: Q1 2021 in Review

Amundi Asset Management US sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 486 shares — an estimated $273K sold.

Amundi Asset Management US first reported a position in BLUE in Q1 2018 and held it in 12 quarters. The position peaked at $14.6M in Q1 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Amundi Asset Management US reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Amundi Asset Management US sold 486 bluebird bio shares in Q1 2021, an estimated $273K.
  • Amundi Asset Management US first reported a position in bluebird bio in Q1 2018 and held it in 12 quarters.
  • Amundi Asset Management US's bluebird bio position peaked at $14.6M in Q1 2019.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.